Portland’s team bus will roll up to McCarthey Athletic Center around 4:30 p.m., roughly two hours before the Pilots tip off against ninth-ranked Gonzaga on Wednesday. That’s about when the Zags might ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Close up of woman's hand setting up intelligent home system, controlling smart home ...

ASH 2025 immunotherapy data highlight the importance of treatment sequencing, real-world outcomes in high-risk populations, and the growing need to define when therapy can be safely de-escalated or ...

Dollar weakness due to Fed rate cuts, tariff uncertainty, and fiscal deficits Trump's comments accelerate dollar index losses Weaker dollar benefits exporters, but raises import costs and inflation ...

Burford has compounded book value per share and realized cash proceeds from litigation matters settled and adjudicated ahead of my original underwriting assumptions. Burford is the only listed ...

On Monday, the Washington Commanders hired Vikings defensive backs coach and passing game coordinator Daronte Jones to be their next defensive coordinator under head coach Dan Quinn. It's a ...

Pete Golding and the Ole Miss Rebels continue tinkering the roster in Oxford this offseason with the program seeing multiple members depart the Magnolia State this month. In what has emerged as a ...

Take A Number: A Striking Figure In Economic News Today Diccon Hyatt is an experienced financial and economics reporter. He's written hundreds of articles breaking down complex financial topics in ...

NORCROSS, Ga. — Police in Gwinnett County are trying to identify a man they said stole different sets of vehicle keys on New Year’s Day. According to Gwinnett County police, on Jan. 1, the ...

As bitcoin wobbles, all eyes are on Strategy . The company, which is the largest public treasury holder of bitcoin, wields considerable power to kneecap the asset's price if it liquidates some of its ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) on Thursday shared topline data from its Phase 2 VISTA trial of PIPE-307, an M1 receptor antagonist for relapsing-remitting multiple sclerosis (RRMS). RRMS ...